Nuclear medicine procedures in diagnosis of pulmonary diseases.
Nuclear medicine studies make it possible to identify areas within the lung where ventilation/perfusion changes have occurred, and allow precise quantification of the regional distribution of ventilation and perfusion.
D000792:Angiography; D001249:Asthma / Q000000981:diagnostic imaging; D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging; D003937:Diagnosis, Differential; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008171:Lung Diseases / Q000000981:diagnostic imaging*; D008173:Lung Diseases, Obstructive / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008722:Methods; D011652:Pulmonary Circulation / Q000187:drug effects; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy; D011660:Pulmonary Heart Disease / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D013300:Streptokinase / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D014692:Ventilation-Perfusion Ratio
D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator